Blood group A: An overseen risk factor for early-onset ovarian hyperstimulation syndrome?

Reproductive BioMedicine Online

Volumn 17, Issue 2, 2008, Pages 185-189

  Binder, Helge ^a   Flegel, Willy A ^b   Emran, Jasmin ^a   Müller, Andreas ^a   Cupisti, Susanne ^a   Beckmann, Matthias W ^a   Eckstein, Reinhold ^a   Dittrich, Ralf ^a   Ringwald, Juergen ^a  

^a UNIVERSITY HOSPITAL ERLANGEN   (Germany)

^b UNIVERSITY HOSPITAL ULM   (Germany)

Author keywords

ABO; Blood group; Case control study; Female infertility; Ovarian hyperstimulation; Von Willebrand factor

Indexed keywords

BLOOD CLOTTING FACTOR 8; BLOOD GROUP ANTIGEN; DALTEPARIN; LOW MOLECULAR WEIGHT HEPARIN; NADROPARIN; VON WILLEBRAND FACTOR;

ADULT; AGE; ARTICLE; BLOOD GROUP A; BLOOD GROUP ABO SYSTEM; BLOOD GROUP O; CAUCASIAN; COHORT ANALYSIS; CONTROLLED STUDY; CRYSTALLOID; DISEASE SEVERITY; EARLY ONASET OVARY HYPERSTIMULATION; FEMALE; FEMALE INFERTILITY; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; OVARY HYPERSTIMULATION; PREGNANCY RATE; RISK FACTOR;

EID: 49749089674     PISSN: 14726483     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1472-6483(10)60193-9     Document Type: Article

References (33)

1. Aird L, Bentall HH, Roberts JA 1953 A relationship between cancer of the stomach and the ABO blood groups. British Medical Journal 1, 799-804.
2. Alan TM 1970 Venous thromboembolism and blood-group. Lancet 1, 303.
3. Bates M 1971 Venous thromboembolic disease and ABO blood type. Lancet 1, 239.
4. Bellver J, Muñoz EA, Ballesteros A et al. 2003 Intravenous albumin does not prevent moderate-severe ovarian hyperstimulation syndrome in high-risk IVF patients: a randomized controlled study. Human Reproduction 18, 2283-2288.
5. Ben-Chetrit A, Eldar-Geva T, Gal M et al. 2001 The questionable use of albumin for the prevention of ovarian hyperstimulation syndrome in an IVF programme: a randomized placebo-controlled trial. Human Reproduction 16, 1880-1884.
6. Binder H, Dittrich R, Hager I et al. 2008 Association of FSH receptor and CYP19A1 gene variations with sterility and ovarian hyperstimulation syndrome. Reproduction 135, 107-116.
7. Binder H, Dittrich R, Einhaus F et al. 2007 Update on ovarian hyperstimulation syndrome: part 1 - incidence and pathogenesis. International Journal of Fertility and Womens Medicine 52, 251-255.
8. Davies JA, Collins PW, Hathaway LS, Bowen DJ 2007 The effect of von Willebrand factor Y/C1584 on in-vivo protein level and function, and interaction with ABO blood group. Blood 109, 2840-2846.
9. Delbaere A, Smits G, Vassart G, Costagliola S 2006 Genetic predictors of ovarian hyperstimulation syndrome in women undergoing in-vitro fertilization. Nature Clinical Practice Endocrinology and Metabolism 2, 590-591.
10. Delvigne A, Rozenberg S 2003 Review of clinical course and treatment of ovarian hyperstimulation syndrome (OHSS). Human Reproduction Update 9, 77-96,
11. Garratty G 2000 Blood groups and disease: a historical perspective. Transfusion Medicine 14, 291-301.
12. Garratty G 1995 Blood group antigens as tumor markers, parasitic/ bacterial/viral receptors, and their association with immunologically important proteins. Immunological Investigations 24, 213-232.
13. Hulstein JJ, van Runnard Heimel PJ, Franx A et al. 2006 Acute activation of the endothelium results in increased levels of active von Willebrand factor in hemolysis, elevated liver enzymes and low platelets (HELLP) syndrome. Journal of Thrombosis and Haemostasis 4, 2569-2575.
14. Jenkins PV, O'Donnell JS 2006 ABO blood group determines plasma von Willebrand factor levels: a biologic function after all? Transfusion 46, 1836-1844.
15. Kaiser UB 2003 The pathogenesis of the ovarian hyperstimulation syndrome. New England Journal of Medicine 349, 729-732.
16. Lurie S, Ben-Aroya Z, Eldar S, Sadan O 2003 Association of Lewis blood group phenotype with preterm premature rupture of membranes. Journal of the Society for Gynecologic Investigation 10, 291-293.
17. Lurie S, Ben-Aroya Z, Eldar S, Sadan O 1998 Association of the Lewis blood-group phenotype with infertility in women. International Journal of Fertility and Women's Medicine 43, 155-158.
18. Mathur R, Evbuomwan I, Jenkins J 2005 Prevention and management of ovarian hyperstimulation syndrome. Current Opinion in Obstetrics and Gynaecology 15, 132-138.
19. Mathur R, Evbuomwan I, Jenkins J 2002 Prevention and management of ovarian hyperstimulation syndrome. Current Opinion in Obstetrics and Gynaecology 12, 111-116.
20. Mathur RS, Akande AV, Keay SD et al. 2000 Distinction between early and late ovarian hyperstimulation syndrome. Fertility and Sterility 73, 901-907.
21. Nefzger MD, Hrubec Z, Chalmers TC 1969 Venous thromboembolism and blood-group. Lancet 1, 887.
22. O'Donnell J, Laffan MA 2001 The relationship between ABO histo-blood group, factor VIII and von Willebrand factor. Transfusion Medicine 11, 343-351.
23. Ogawa S, Minakami H, Araki S et al. 2001 A rise of the serum level of von Willebrand factor occurs before clinical manifestation of the severe form of ovarian hyperstimulation syndrome. Journal of Assisted Reproduction 18, 114-119.
24. Omu AE, Al-Mutawa M, Al-Qattan F 1998 ABO blood group and expression of antisperm antibodies in infertile couples in Kuwait. Gynecologic and Obstetric Investigation 45, 49-53.
25. Papanikolaou EG, Tournaye H, Verpoest W et al. 2005 Early and late ovarian hyperstimulation syndrome: early pregnancy outcome and profile. Human Reproduction 20, 636-641.
26. Rizk B 2006 Ovarian Hyperstimulation Syndrome. Cambridge University Press, Cambridge USA, pp. 1-129.
27. Schaap T, Shemer R, Palti Z, Sharon R 1984 ABO incompatibility and reproductive failure. I. Prenatal selection. American Journal of Human Genetics 36, 143-151.
28. Schenker JG, Weinstein D 1978 Ovarian hyperstimulation syndrome: a current survey. Fertility and Sterility 30, 255-268.
29. Sharara AI, Abdul-Baki H, Elhajj I et al. 2006 Association of gastroduodenal disease phenotype with ABO blood group and Helicobacter pylori virulence-specific serotypes. Digestive and Liver Disease 38, 829-833.
30. Solish GI, Gershowitz H 1969 Distribution of ABO blood types among fertile and infertile women. American Journal of Human Genetics 21, 23-35.
31. Todorow S, Schricker ST, Siebzehnruebl ER et al. 1993 Von Willebrand factor: an endothelial marker to monitor in-vitro fertilization patients with ovarian hyperstimulation syndrome. Human Reproduction 8, 2039-2046.
32. Tousoulis D, Antoniades C, Bosinakou E et al. 2007 Differences in inflammatory and thrombotic markers between unstable angina and acute myocardial infarction. International Journal of Cardiology 115, 203-207.
33. Zöfel P 2002 Statistik Verstehen [Understanding Statistics]. Addison-Wesley Verlag, Munich Germany.